Needham & Company
-
AtriCure Inc. (ATRC) PT Raised to $58 at Needham & Company, adds to Conviction List
-
Livanova (LIVN) Named Top 2022 Pick at Needham & Company
-
Livanova (LIVN) PT Raised to $120 at Needham & Company
-
Livanova (LIVN) PT Raised to $104 at Needham & Company
-
Needham & Company Upgrades Livanova (LIVN) to Buy; 'Guidance Appears Conservative, DTD Catalyst Approaching'
-
UPDATE: Needham & Company Downgrades Livanova (LIVN) to Hold; Fairly Valued and Lack of Pipeline Catalysts
-
Livanova (LIVN) PT Lowered to $88 at Needham & Company
-
Livanova (LIVN) PT Raised to $91 at Needham & Company
-
Livanova (LIVN) PT Lowered to $87 at Needham & Company
-
Livanova (LIVN) PT Lowered to $100 at Needham & Company, Says Problems Temporary
-
LivaNova to Present at the Needham Healthcare Conference
-
Livanova (LIVN) PT Lowered to $129 at Needham & Company
-
Livanova (LIVN) PT Raised to $135 at Needham & Company
-
Livanova (LIVN) PT Raised to $106 at Needham & Company as CMS to Reconsider Coverage of VNS for Treatment-Resistant Depression
-
LivaNova to Present at the Needham & Company Healthcare Conference
-
Livanova (LIVN) PT Raised to $104 at Needham & Company
-
Livanova (LIVN) PT Raised to $93 at Needham & Company, 'Selling CRM Business Is Accretive to Growth, Dilutive to EPS'
-
Livanova (LIVN) PT Raised to $89 at Needham & Company Following 3Q Beat and Raise
-
UPDATE: Needham & Company Upgrades Livanova (LIVN) to Buy
-
Needham & Company Starts Livanova (LIVN) at Hold

